AdvisorShares Psychedelics ETF

Lønnsomhet i seks måneder: 54.1%
Industri: Health & Biotech Equities

Mind Medicine (MindMed) Inc.
COMPASS Pathways plc
Relmada Therapeutics, Inc.
Alkermes plc
Intra-Cellular Therapies, Inc.
Atai Life Sciences N.V.
GH Research PLC
Sage Therapeutics, Inc.
Greenbrook TMS Inc.
Hvile
Mind Medicine (MindMed) Inc.: 13.8%COMPASS Pathways plc: 6.7%Relmada Therapeutics, Inc.: 5.1%Alkermes plc: 5%Intra-Cellular Therapies, Inc.: 4.6%Atai Life Sciences N.V.: 4.3%GH Research PLC: 4.2%Sage Therapeutics, Inc.: 3.7%Hvile: 52.4%Del andel etter selskapno.porti.ru
Last ned SVG
Last ned PNG
Last ned CSV
NavnIndustriDele, %P/BVP/SP/EEV/EbitdaUtbytte
Mind Medicine (MindMed) Inc. Healthcare 13.7652 1.94 0 0 -0.7272 0
COMPASS Pathways plc COMPASS Pathways plc Healthcare 6.71965 2 0 0 -1.92 0
Relmada Therapeutics, Inc. Relmada Therapeutics, Inc. Healthcare 5.08039 1.08 0 0 -0.8487 0
Alkermes plc Alkermes plc Healthcare 4.99899 3.32 3.13 13.27 11.06 0
Intra-Cellular Therapies, Inc. Intra-Cellular Therapies, Inc. Healthcare 4.59804 7.5 12.65 0 -71.28 0
Atai Life Sciences N.V. Atai Life Sciences N.V. Healthcare 4.32468 1.83 691.6 0 -1.4 0
GH Research PLC Healthcare 4.2406 2.04 0 0 -5.09 0
Sage Therapeutics, Inc. Sage Therapeutics, Inc. Healthcare 3.69571 0.7095 8 2.85 -0.6031 0
Greenbrook TMS Inc. Healthcare 0.20913 0 0 0 0 0
47.642.2779.491.79-7.870.00000

Betal for abonnementet ditt

Mer funksjonalitet og data for selskaps- og porteføljeanalyse er tilgjengelig med abonnement